key: cord-0733238-47abo1xp
authors: Breslin, Noelle; Baptiste, Caitlin; Gyamfi-Bannerman, Cynthia; Miller, Russell
title: Reply
date: 2020-06-20
journal: Am J Obstet Gynecol MFM
DOI: 10.1016/j.ajogmf.2020.100161
sha: 23fd753de10de00e9bb010876049ecb731f34044
doc_id: 733238
cord_uid: 47abo1xp

nan

We appreciate the points raised in these letters to the editors regarding our recent article. 1 We agree that differences in age and testing strategies challenge our ability to formally compare data from our small study group of pregnant women with those from the general nonpregnant population, and in our discussion, we cautioned that our basic impression that these groups seemed similar "may be false and misleading."

That being said, this is not clearly an "apples and oranges" comparison either, and in reality, mounting data suggest that these groups may be closer to "tangerines and clementines." Ultimately, we cautioned that ". until more evidence is available, there is a reason to remain concerned for the clinical course of COVID-19 [coronavirus disease 2019] in pregnant women, despite encouraging early experiences here and elsewhere," and we encouraged further research. We continue to feel that more information is needed and believe that we can all agree on this final point.

COVID-19 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals

This paper is part of a supplement that represents a collection of COVIDrelated articles selected for publication by the editors of AJOG MFM without additional financial support.The authors report no conflict of interest.